REFERENCES
- Malone D C, Lawson K A, Smith D H, Arrighi H M, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997; 99: 22–27, [PUBMED], [INFOTRIEVE], [CSA]
- Chapin M J, George M A, Abelson M B. Olopatadine: Broadening choices for the treatment of allergic conjunctivitis. Todays Therapeutic Trends. 1999; 17(1)67–84
- Dart J KG, Buckley R J, Monnickendan M, Prasad J. Perennial allergic conjunctivitis: Definition, clinical characteristics and prevalence. Trans Ophthalmol Soc UK 1986; 105: 513–520, [PUBMED], [INFOTRIEVE]
- Leonardi A. Pathophysiology of allergic conjunctivitis. Acta Ophthalmol Scand. 1999; 77: 21–3
- McMenamin P. Costs of hay fever in the United States in 1990. Ann Allergy. 1994; 73: 35–39, [PUBMED], [INFOTRIEVE], [CSA]
- Ray N F, Baraniuk J N, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contribution of related airway illnesses. J Allergy Clin Immunol. 1999; 103: 401–407, [PUBMED], [INFOTRIEVE], [CSA]
- Juniper E F, Guyatt G H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991; 21: 77–83, [PUBMED], [INFOTRIEVE]
- Juniper E F, Thompson A K, Ferrie P J, Roberts J N. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999; 104: 364–369, [PUBMED], [INFOTRIEVE], [CSA]
- Pitt A D, Smith A F, Lyndsell L, et al. Economic and quality of life impact of seasonal allergic conjunctivitis in Oxfordshire. Ophthalmic Epidemiol. 2004; 11(1)17–33, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Frenz D A, Palmer M A, Hokanson J M, Scamehorn R T. Seasonal characteristic of ragweed pollen disperal in the United Status. Ann Allergy Asthma Immunol. 1995; 75(5)417–422, [PUBMED], [INFOTRIEVE], [CSA]
- World Health Organisation, www.who.int/country/esp/en/ 27 November 2003
- Censo de Población y Vivienda 2001. Instituto Nacional de Estadística, España (1-11-2001), www.ine.es/censo2001/censos
- December, 22002, EuroQoL EQ-5D: http://www.euroQoL.org/
- Juniper E F. Rhinitis management: the patient's perspective. Clin Exp Allergy 1998; 28: 34–38, Supp 6[PUBMED], [INFOTRIEVE], [CROSSREF]
- National Eye Institute VFQ. December, 22002, http://www.nei.nih.gov/resources/visionfunction/vfq_sa.pdf
- Mangione C M, Lee P P, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol. 1998; 116: 1496–1504, [PUBMED], [INFOTRIEVE], [CSA]
- Mangione C M, Lee P P, Gutierrez P R, et al. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001; 119: 1050–1058, [PUBMED], [INFOTRIEVE], [CSA]
- Economic and financial indicators. The Economist Magazine. August, 232003, 82
- Crystal-Peters J, Neslusan C A, Smith M W, Togias A. Health care costs of allergic rhinitis-associated conditions vary with allergy season. Ann Allergy Asthma Immunol. 2002; 89: 457–462, [PUBMED], [INFOTRIEVE], [CSA]
- Schramm B, Ehlken B, Smala A, et al. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J. 2003; 21: 116–122, [PUBMED], [INFOTRIEVE], [CROSSREF]
- OECD website. November, 302003, http://www.oecd.org/dataoecd/48/18/18598721.pdf
- Pedersen P A, Weeke E R. Asthma and allergic rhinitis in the same patients. Allergy. 1983; 38: 25–29, [PUBMED], [INFOTRIEVE]
- Evans R, 3rd, Mullally D I, Wilson R W, et al. National trends in the morbidity and mortality of asthma in the US. Prevalence, hospitalization and death from asthma over two decades, 1965–1984. Chest 1987; 91: 65S–74S, (Suppl)[PUBMED], [INFOTRIEVE]